Fierce Pharma
NOVEMBER 27, 2024
The competition among three TROP2 antibody-drug conjugates is ent | The competition among three TROP2 antibody-drug conjugates is entering a new stage as Kelun-Biotech’s Merck & Co.-partnered sacituzumab tirumotecan has become the second therapy in the class to win a marketing approval.
Pharmaceutical Technology
NOVEMBER 27, 2024
Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 27, 2024
Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer antidepressant, reduced bouts of cataplexy and other narcolepsy symptoms in Axsome's ENCORE study.
Pharmaceutical Technology
NOVEMBER 27, 2024
In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic conditions such as rheumatoid arthritis and psoriasis, where biologics have also transformed treatment paradigms.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
NOVEMBER 27, 2024
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be reconfigured within days during a pandemic—the drugmaker said it has
pharmaphorum
NOVEMBER 27, 2024
Novartis' fast-growing breast cancer drug gets another growth driver as EU approves adjuvant use in patients with early-stage HR+, HER2- tumours.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
NOVEMBER 27, 2024
AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with ATTR polyneuropathy
Fierce Pharma
NOVEMBER 27, 2024
On a routine basis in recent years, headlines about layoffs in the biopharma industry have surfaced as companies large and small have been cutting costs and restructuring. | A survey of life sciences CEOs found that 94% plan to grow their workforce over the next three years, with 37% envisioning that the head count of their company will grow by at least 6%.
Pharmacy Times
NOVEMBER 27, 2024
In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.
European Pharmaceutical Review
NOVEMBER 27, 2024
Researchers have developed a novel, cost-effective bacterial system for production of fully endotoxin-free recombinant proteins. Lipopolysaccharides (LPS)-deficient Acinetobacter baumannii was used for the purification of recombinant proteins. Positively, conducting an assay test demonstrated an ability to suppress viral infection. The team shared in their paper that there is “ample scope for enhancing the yield of recombinant proteins” yet currently, this is lower than that of existing E. coli
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
NOVEMBER 27, 2024
In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new InPen app, setting the stage for the launch of the company’s Smart MDI system integrated with the Simplera continuous glucose monitor (CGM).
Contrarian Sales Techniques
NOVEMBER 27, 2024
Selling pharmaceuticals isn’t just about pushing a single product anymore. Especially in Malaysia, where healthcare needs are diverse, success often comes down to how well you can offer solutions that truly make a difference. That’s where portfolio selling comes in. Instead of focusing on one product at a time, this approach helps pharma reps present a range of options that work together.
Pharmacy Times
NOVEMBER 27, 2024
Pharmacists are well-positioned to address diabetes from a multifaceted approach.
Pharmaceutical Commerce
NOVEMBER 27, 2024
Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmacy Times
NOVEMBER 27, 2024
Methemoglobinemia is a blood disorder that affects proper release of oxygen around the body.
Pharmaceutical Technology
NOVEMBER 27, 2024
Discover the leading lead generation providers and technology solutions tailored for the pharmaceutical industry. Download our guide for industry insights and technology solution information.
Pharmacy Times
NOVEMBER 27, 2024
However, pharmacists can help mitigate these effects.
PharmExec
NOVEMBER 27, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
NOVEMBER 27, 2024
The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.
Pharmaceutical Technology
NOVEMBER 27, 2024
With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative market.
Pharmacy Times
NOVEMBER 27, 2024
Trends across small cell lung cancer (SCLC) and diffuse large B-cell lymphoma (DLBCL) emphasize the need to further improve global treatment options.
Pharmaceutical Technology
NOVEMBER 27, 2024
The EC has approved BeiGene’s PD-1 inhibitor Tevimbra in combination with chemotherapy to treat ESCC and G/GEJ adenocarcinoma.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
NOVEMBER 27, 2024
Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.
PharmExec
NOVEMBER 27, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
NOVEMBER 27, 2024
The proposed rule would increase access to semaglutide for millions of Americans.
Pharmaceutical Technology
NOVEMBER 27, 2024
The EC has granted approval to Novartis' Kisqali (ribociclib) plus an aromatase inhibitor to treat early breast cancer patients.
PharmaVoice
NOVEMBER 27, 2024
Lindus Health’s women-focused CRO is the latest in a handful of research efforts to target specialized — and underrepresented — populations.
Pharmaceutical Technology
NOVEMBER 27, 2024
The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava last year.
pharmaphorum
NOVEMBER 27, 2024
Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure.
Pharmaceutical Technology
NOVEMBER 27, 2024
Idorsia has extended its cash runway into 2025 via an exclusivity fee for global rights negotiations for Tryvio.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
304 
Let's personalize your content